GET THE APP

..

Nuclear Medicine & Radiation Therapy

ISSN: 2155-9619

Open Access

Citations Report

Nuclear Medicine & Radiation Therapy : Citations & Metrics Report

Articles published in Nuclear Medicine & Radiation Therapy have been cited by esteemed scholars and scientists all around the world.

Nuclear Medicine & Radiation Therapy has got h-index 12, which means every article in Nuclear Medicine & Radiation Therapy has got 12 average citations.

Following are the list of articles that have cited the articles published in Nuclear Medicine & Radiation Therapy.

  2024 2023 2022 2021 2020 2019 2018

Total published articles

50 52 63 62 11 17 49

Research, Review articles and Editorials

212 112 0 0 0 0 0

Research communications, Review communications, Editorial communications, Case reports and Commentary

545 458 0 0 0 0 0

Conference proceedings

0 0 0 0 0 0 22

Citations received as per Google Scholar, other indexing platforms and portals

757 570 69 80 82 74 61
Journal total citations count 706
Journal impact factor 2.03
Journal 5 years impact factor 1.8
Journal cite score 1.98
Journal h-index 12
Journal h-index since 2019 9
Important citations

Whittle, Sarah B., Valeria Smith, Erin Doherty, Sibo Zhao, Scott McCarty, and Peter E. Zage. "Overview and recent advances in the treatment of neuroblastoma." Expert review of anticancer therapy 17, no. 4 (2017): 369-386.

Babu, Manas. "Radiation risks in urologic practice." Astrocyte 2, no. 2 (2015): 77.

Rezaei, Sahar, Pardis Ghafarian, Abhinav K. Jha, Arman Rahmim, Saeed Sarkar, and Mohammad Reza Ay. "Joint compensation of motion and partial volume effects by iterative deconvolution incorporating wavelet-based denoising in oncologic PET/CT imaging." Physica Medica 68 (2019): 52-60.

Yamamoto, Takaya, Noriyuki Kadoya, Yuko Shirata, Tomohiro Kaneta, Masashi Koto, Rei Umezawa, Youjirou Ishikawa et al. "Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapy." Annals of nuclear medicine 29, no. 8 (2015): 666-673.

Santos-de-Frutos, Karla, and Nabil Djouder. "When dormancy fuels tumour relapse." Communications Biology 4, no. 1 (2021): 1-12.

Providência, L., Domingues, I., & Santos, J. (2021). An Iterative Algorithm for Semisupervised Classification of Hotspots on Bone Scintigraphies of Patients with Prostate Cancer. Journal of Imaging, 7(8), 148.lauraprovid@hotmail.com

Georgiou, M., Kuker, R. A., Studenski, M., Ahlman, P. P., Witte, M., & Portelance, L. (2021). Lung Shunt Fraction Calculation Using 99mTc-MAA SPECT/CT Imaging for 90Y Microsphere Selective Internal Radiation Therapy of Liver Tumors.

Asadian, S., Mirzaei, H., Kalantari, B. A., Davarpanah, M. R., Mohamadi, M., Shpichka, A., ... & Vosough, M. (2020). ?-radiating radionuclides in cancer treatment, novel insight into promising approach. Pharmacological Research, 105070.

Fleming, R. M., & Fleming, M. R. (2020). FMTVDM-Finally Opens the Doorway from Qualitative to Quantitative Measurement and Treatment of Heart Disease. J Cardiovasc Med Cardiol, 7(2), 060-062.

Fleming, R. M., Fleming, M. R., de la Fuente, L. M., & Peñaloza, F. E. (2020). The Impact of Low Carb-KETO Diets on CAD-Why more Research is needed. Journal of Cardiovascular Medicine and Cardiology, 7(2), 110-120.

Fleming, R. M. (2019). Unmasking Hidden Recurrent Cancers using FMTVDM/BEST: The Fleming Cancer Hypothesis. Int J Womens Health Well-ness, 5(094), 2474-1353.

Fleming, R. M. (2019). Unmasking Hidden Recurrent Cancers using FMTVDM/BEST: The Fleming Cancer Hypothesis. Int J Womens Health Well-ness, 5(094), 2474-1353.

Fleming, R. M. (2019). Unmasking Hidden Recurrent Cancers using FMTVDM/BEST: The Fleming Cancer Hypothesis. Int J Womens Health Well-ness, 5(094), 2474-1353.

Fleming, R. M., Fleming, M. R., Chaudhuri, T. K., Dooley, W. C., & Mc Kusick, A. (2019). FMTVDM/BEST©? Imaging for Women with Breast Implants and Dense Breasts. Int J Womens Health Wellness, 5(092), 2474-1353.

Fleming, R. M., Fleming, M. R., Chaudhuri, T. K., & Kusick, A. M. (2019). FMTVDM© â „—Provides the First Patented Quantification of Myocardial Perfusion Imaging (MPI) Yielding Theranostic Benefit for Individuals with Suspected Coronary Artery Disease (CAD). Biomedical Journal of Scientific & Technical Research, 13(5), 10329-10332.

Fleming, R. M., Fleming, M. R., Chaudhuri, T. K., & Kusick, A. M. (2019). FMTVDM© â „—Provides the First Patented Quantification of Myocardial Perfusion Imaging (MPI) Yielding Theranostic Benefit for Individuals with Suspected Coronary Artery Disease (CAD). Biomedical Journal of Scientific & Technical Research, 13(5), 10329-10332.

Contreras, Carlos. "Mathematical modelling of the effect of low-dose radiation on the G2/M transition and the survival fraction via the ATM/Chk2 pathway." (2020).

Bell, Clayton, Kyle Potts, Mary Hitt, Desmond Pink, Jack Tuszynski, and John D. Lewis. "Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma." Cancer Letters (2021).

Bell, Clayton James. "CR42-24, a Novel Colchicine Derivative, as a Therapy for Bladder Cancer." (2018).

Nair, Jyothi, Poorvaja Muley, and Shilpee Dutt. "Therapy induced senescence and its implications in cancer." Cancer 1, no. 2 (2017): 1-2.

Google Scholar citation report
Citations: 706

Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report

Nuclear Medicine & Radiation Therapy peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward